Compare ALGM & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALGM | RGEN |
|---|---|---|
| Founded | 1990 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.6B |
| IPO Year | 2007 | 1995 |
| Metric | ALGM | RGEN |
|---|---|---|
| Price | $49.21 | $119.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $44.27 | ★ $167.67 |
| AVG Volume (30 Days) | ★ 1.8M | 869.6K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | 0.01 | ★ 0.86 |
| Revenue | ★ $725,006,000.00 | $141,236,000.00 |
| Revenue This Year | $24.20 | $14.30 |
| Revenue Next Year | $17.94 | $14.52 |
| P/E Ratio | $4,872.00 | ★ $136.39 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $18.17 | $109.50 |
| 52 Week High | $49.19 | $175.77 |
| Indicator | ALGM | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 76.32 | 47.58 |
| Support Level | $29.55 | $110.99 |
| Resistance Level | N/A | $130.12 |
| Average True Range (ATR) | 1.90 | 6.06 |
| MACD | 0.82 | -0.61 |
| Stochastic Oscillator | 93.56 | 30.17 |
Allegro Microsystems Inc is a designer, developer, fabless manufacturer, and marketer of sensor ICs and application-specific analog power ICs for automotive and industrial markets. Its Sensor IC allows customers to precisely measure motion, speed, position, and current, and Power ICs include high-temperature and high-voltage capable motor drivers, power management, and LED driver ICs. Its products are divided into three categories such as SENSE which includes Current Sensors, Switches and Latches, and Interface ICs among others; REGULATE which includes Regulators, ClearPower Modules, and LED Drivers; and DRIVE which includes BLDC Drivers, Brush DC, and others. Key revenue for the company is generated from Greater China and the rest from the United States, Japan, Europe, and other regions.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.